Incidence of Reflux Esophagitis After Pancreaticoduodenectomy

Status Recruiting

Clinical Trial Summary

Reflux esophagitis is a common complication following distal gastrectomy. According to the investigators preliminary data, an Roux-en--Y gastrointestinal reconstruction in pancreaticoduodenectomy is associated with higher rates of reflux esophagitis. In this study, the investigators will investigate the incidence of reflux esophagitis after above procedure by the 24-h pH monitoring of esophagogastric junction.

Clinical Trial Description

Reflux esophagitis is a common complication following distal gastrectomy. Recently, an Roux-en--Y gastrointestinal reconstruction has been used increasingly to prevent reflux esophagitis; however, reflux esophagitis after pancreaticoduodenectomy (also including distal gastrectomy) has never been studied.

In our preliminary retrospective study of 371 patients having PD (158 standard PD and 213 pylorus-preserving PD) at our hospital, after a median follow-up of 20 months (range, 2-110 months), 40 patients (10.8%) developed reflux esophagitis — 15 (9.5%) in the standard PD group, and 25 (11.7%) in the PPPD group. Multivariate logistic regression analysis revealed the only significant factors related to reflux esophagitis is Roux-en-Y gastrointestinal reconstruction independent of preservation of the pylorus.

To our surprise, there is no significant difference in occurrence of GERD between patients after standard PD (15 of 158 patient) and PPPD (25 of 313 patients, P=0.49). We postulate reflux esophagitis following a PPPD in patients without past history of GERD is most likely caused by disruption of reflux-preventing systems at the gastroesophageal junction, thereby allowing reflux of gastric acid into esophagus. If the postulation is true, GERD after PPPD should be acidic in nature. To test this hypothesis we propose a prospective randomized study to compare preoperative and postoperative parameters, including esophageal morphology, bile acid concentration, trypsin activity of esophageal refluxate, COX2 mRNA expression of lower esophageal mucosa, and 24 hour pH monitor of lower esophagus.

Moreover, to test the effect of a Roux-en-Y reconstruction to prevent GERD after PD, studied patients will be randomized into Roux-en-Y and control groups to study inter-group differences in incidence of GERD and marginal ulcer after PD.

Acidic GERD should be treated with proton pump inhibitor. In contrast, alkaline GERD should be treated with pro-kinetic agent such as primperan and mopride. With this study, we can learn more about the nature of post-PD GERD following various gastrointestinal reconstructions and can give patient more personalized therapy. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01311908
Study type	Observational
Source	National Taiwan University Hospital
Contact	Yu-Wen Tien, M.D., Ph.D.
Email	Ywtien5106@ntu.edu.tw
Status	Recruiting
Phase	N/A
Start date	March 2011
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06170060` - Treatment of Reflux With Sleeve Gastrectomy	N/A
Not yet recruiting	`NCT06062225` - Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy	N/A
Completed	`NCT01964131` - BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects	Phase 1
Not yet recruiting	`NCT06056973` - Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis	Phase 4
Completed	`NCT01008696` - An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis	Phase 4
Recruiting	`NCT05899491` - Role of ARMA in Selective Subset of Refractory GERD Patients.	N/A
Completed	`NCT03214081` - Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
Not yet recruiting	`NCT01560598` - Adipokines and the Risk of Reflux Esophagitis	N/A
Completed	`NCT00859287` - Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis	N/A
Completed	`NCT00206180` - NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis	Phase 4
Recruiting	`NCT04657848` - Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy	N/A
Completed	`NCT02477475` - Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes	N/A
Completed	`NCT03553563` - A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer	Phase 3
Completed	`NCT01381991` - The Efficacy of i-Scan for Detecting Reflux Esophagitis	N/A
Completed	`NCT04673643` - Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Reflux Esophagitis	N/A
Recruiting	`NCT04531475` - Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis	Phase 2
Completed	`NCT00634114` - Reflux Esophagitis Phase III Study (Maintenance Treatment)	Phase 3
Completed	`NCT00586963` - Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis	N/A
Completed	`NCT03388047` - Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus	N/A
Recruiting	`NCT00155805` - Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus	N/A